These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 29040985)

  • 1. Serum IFN-λ3 Levels Correlate with Serum Hepatitis C Virus RNA Levels in Symptomatic Patients with Acute Hepatitis C.
    Imoto S; Kim SR; Amano K; Iio E; Yoon S; Hirohata S; Yano Y; Ishikawa T; Katsushima S; Komeda T; Fukunaga T; Chung H; Kokuryu H; Horie Y; Hatae T; Fujinami A; Kim SK; Kudo M; Tanaka Y
    Dig Dis; 2017; 35(6):531-540. PubMed ID: 29040985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infection.
    Beinhardt S; Aberle JH; Strasser M; Dulic-Lakovic E; Maieron A; Kreil A; Rutter K; Staettermayer AF; Datz C; Scherzer TM; Strassl R; Bischof M; Stauber R; Bodlaj G; Laferl H; Holzmann H; Steindl-Munda P; Ferenci P; Hofer H
    Gastroenterology; 2012 Jan; 142(1):78-85.e2. PubMed ID: 22192885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum IFN-λ3 with inflammatory and fibrosis markers in patients with chronic hepatitis C virus infection.
    Aoki Y; Sugiyama M; Murata K; Yoshio S; Kurosaki M; Hashimoto S; Yatsuhashi H; Nomura H; Kang JH; Takeda T; Naito S; Kimura T; Yamagiwa Y; Korenaga M; Imamura M; Masaki N; Izumi N; Kage M; Mizokami M; Kanto T
    J Gastroenterol; 2015 Aug; 50(8):894-902. PubMed ID: 25501286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.
    Wiegand SB; Heidrich B; Susser S; Rogalska-Taranta M; Petersen J; Böker KH; Grigorian N; Link R; Naumann U; John C; Lueth S; Malfertheiner P; Manns MP; Wedemeyer H; Sarrazin C; Cornberg M
    PLoS One; 2015; 10(12):e0145622. PubMed ID: 26699619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult hepatitis C virus infection in hemophilia patients and its correlation with interferon lambda 3 and 4 polymorphisms.
    Nafari AH; Ayadi A; Noormohamadi Z; Sakhaee F; Vaziri F; Siadat SD; Fateh A
    Infect Genet Evol; 2020 Apr; 79():104144. PubMed ID: 31838260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-λ3 polymorphisms in pegylated-interferon-α plus ribavirin therapy for genotype-2 chronic hepatitis C.
    Ishiguro H; Abe H; Seki N; Sugita T; Aida Y; Itagaki M; Sutoh S; Shimada N; Furihata T; Tsubota A; Aizawa Y
    World J Gastroenterol; 2015 Apr; 21(13):3904-11. PubMed ID: 25852275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection.
    Eslam M; Leung R; Romero-Gomez M; Mangia A; Irving WL; Sheridan D; Spengler U; Mollison L; Cheng W; Bugianesi E; McLeod D; Zaitoun AM; Attino V; Goeltz D; Nattermann J; Douglas M; Booth DR; George J; Ahlenstiel G
    J Hepatol; 2014 Aug; 61(2):235-41. PubMed ID: 24768758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of
    Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
    World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepatitis C virus in haemodialysis patients: a case-control study.
    Grzegorzewska AE; Mostowska A; Świderska MK; Marcinkowski W; Stolarek I; Figlerowicz M; Jagodziński PP
    BMC Infect Dis; 2021 Jan; 21(1):102. PubMed ID: 33482747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFNL3 mediates interaction between innate immune cells: Implications for hepatitis C virus pathogenesis.
    O'Connor KS; Ahlenstiel G; Suppiah V; Schibeci S; Ong A; Leung R; van der Poorten D; Douglas MW; Weltman MD; Stewart GJ; Liddle C; George J; Booth DR
    Innate Immun; 2014 Aug; 20(6):598-605. PubMed ID: 24045339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to HBV surface antigen in relation to interferon-λ3 in hemodialysis patients.
    Grzegorzewska AE; Świderska MK; Mostowska A; Warchoł W; Jagodziński PP
    Vaccine; 2016 Sep; 34(41):4866-4874. PubMed ID: 27595449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism in interferon λ3/interleukin-28B gene and risk to noncirrhotic chronic hepatitis C genotype 3 virus infection and its effect on the response to combined daclatasvir and sofosbuvir therapy.
    Khan AJ; Saraswat VA; Ranjan P; Parmar D; Negi TS; Mohindra S
    J Med Virol; 2019 Apr; 91(4):659-667. PubMed ID: 30431653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of interferon λ3 gene polymorphisms, rs8099917 and rs12979860, on response to hepatitis B virus vaccination and hepatitis B or C virus infections among hemodialysis patients.
    Grzegorzewska AE; Jodłowska E; Mostowska A; Jagodziński P
    Pol Arch Med Wewn; 2015; 125(12):894-902. PubMed ID: 26658164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Interferon-
    Grzegorzewska AE; Świderska MK; Mostowska A; Jagodziński PP
    Biomed Res Int; 2017; 2017():3713025. PubMed ID: 29226133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
    O'Brien TR; Pfeiffer RM; Paquin A; Lang Kuhs KA; Chen S; Bonkovsky HL; Edlin BR; Howell CD; Kirk GD; Kuniholm MH; Morgan TR; Strickler HD; Thomas DL; Prokunina-Olsson L
    J Hepatol; 2015 Nov; 63(5):1103-10. PubMed ID: 26186989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapy.
    Aziz H; Raza A; Ali K; Khattak JZ; Irfan J; Gill ML
    Int J Infect Dis; 2015 Jan; 30():91-7. PubMed ID: 25462177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in the IFNL3/IL28B gene and hepatitis C: from adults to children.
    Indolfi G; Azzari C; Resti M
    World J Gastroenterol; 2014 Jul; 20(28):9245-52. PubMed ID: 25071317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered effector functions of NK cells in chronic hepatitis C are associated with IFNL3 polymorphism.
    Rogalska-Taranta M; Markova AA; Taranta A; Lunemann S; Schlaphoff V; Flisiak R; Manns MP; Cornberg M; Kraft AR; Wedemeyer H
    J Leukoc Biol; 2015 Aug; 98(2):283-94. PubMed ID: 26034208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFNL3 genotype is associated with differential induction of IFNL3 in primary human hepatocytes.
    Kurbanov F; Kim Y; Latanich R; Chaudhari P; El-Diwany R; Knabel M; Kandathil AJ; Cameron A; Cox A; Jang YY; Thomas DL; Balagopal A
    Antivir Ther; 2015; 20(8):805-14. PubMed ID: 26109548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High spontaneous clearance of symptomatic iatrogenic acute hepatitis C genotype 4 infection.
    Hashem M; Zaghla H; Zakaria Z; Allam WR; Sameea EA; Mikhail NN; Sobhy M; Galal IF; Mokhtar Y; Hamdy S; Galal G; Abdelwahab SF; Waked I
    J Med Virol; 2018 Dec; 90(12):1841-1847. PubMed ID: 30011346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.